Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

NCT: NCT04763200 · ACTIVE_NOT_RECRUITING

NCT IDNCT04763200
StatusACTIVE_NOT_RECRUITING
Start Date2021-04-13
Completion2027-10
SponsorAbiomed Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.

Frequently Asked Questions

What is Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function?

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function is a clinical trial registered under NCT04763200. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04763200?

The current status of NCT04763200 (Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function) is: ACTIVE_NOT_RECRUITING.

When did Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function start?

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function started on 2021-04-13.

Related Devices

PMA P140003Temporary non-roller type left heart support blood pumpAbiomed, Inc. K192769Impella CP IntroducerAbiomed, Inc. K200109OXY-1 SystemAbiomed, Inc. K201116Abiomed 23 Fr SheathAbiomed, Inc. K202330Impella XR Sheath SetAbiomed, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑